These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8746285)

  • 21. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
    Jeejeebhoy F; Keith M; Freeman M; Barr A; McCall M; Kurian R; Mazer D; Errett L
    Am Heart J; 2002 Jun; 143(6):1092-100. PubMed ID: 12075268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction.
    Singh RB; Niaz MA; Agarwal P; Begom R; Rastogi SS
    J Am Diet Assoc; 1995 Jul; 95(7):775-80. PubMed ID: 7797808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
    Benvenga S; Ruggeri RM; Russo A; Lapa D; Campenni A; Trimarchi F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3579-94. PubMed ID: 11502782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery.
    Pastoris O; Dossena M; Foppa P; Catapano M; Arbustini E; Bellini O; Dal Bello B; Minzioni G; Ceriana P; Barzaghi N
    Pharmacol Res; 1998 Feb; 37(2):115-22. PubMed ID: 9572066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
    Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
    J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
    Kopecky SL; Aviles RJ; Bell MR; Lobl JK; Tipping D; Frommell G; Ramsey K; Holland AE; Midei M; Jain A; Kellett M; Gibbons RJ;
    Am Heart J; 2003 Jul; 146(1):146-52. PubMed ID: 12851624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.
    DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
    Mayo Clin Proc; 2013 Jun; 88(6):544-51. PubMed ID: 23597877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central haemodynamics in acute myocardial infarction. Natural history, relation to enzyme release and effects of metoprolol.
    Held P
    Acta Med Scand Suppl; 1986; 709():1-47. PubMed ID: 3532697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
    J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.
    Cruciani RA; Dvorkin E; Homel P; Culliney B; Malamud S; Lapin J; Portenoy RK; Esteban-Cruciani N
    J Pain Symptom Manage; 2009 Apr; 37(4):622-31. PubMed ID: 18809275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.
    Eur Heart J; 1985 Mar; 6(3):199-226. PubMed ID: 2863148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of metabolic therapy in myocardial infarct].
    Di Biase M; Biasco G; Rizzon P
    Cardiologia; 1991 Dec; 36(12 Suppl 1):389-92. PubMed ID: 1841795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial.
    Miyagawa T; Kawamura H; Obuchi M; Ikesaki A; Ozaki A; Tokunaga K; Inoue Y; Honda M
    PLoS One; 2013; 8(1):e53707. PubMed ID: 23349733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.